Looking to publish in Current Research in Translational Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCurrent Research in Translational Medicine is a peer-reviewed electronic journal publishing worldwide clinical and basic research in hematology, immunology, hematopoietic cell transplantation, cellular and gene therapy, RNA biology including vaccines and related research, and artificial intelligence in medicine and bioinformatics. It publishes 4 issues per year and considers editorials, original articles, state-of-the-art articles, reviews, short reports, clinical images, and letters to the editors.
Looking to publish in Current Research in Translational Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Current Research in Translational Medicine accepts the following article types. Click on an article type to view submission instructions.
Original Article
State-Of-The-Art Articles
General Review
Short Reports
Clinical Image
Letter To The Editor
Brief Communication
Recent Publications
Post-Transplant Lineage Transformation to Blastic Plasmacytoid Dendritic Cell Neoplasm in Advanced Systemic Mastocytosis with Associated CMML: A Case Report
Omar Khaled, Alexander Woodman, Camron Farjami, Zachary Goldstein, Eric Leon Tam, Karrune Woan, Preet Chaudhary, Amir Ali, Imran S Siddiqi, George Yaghmour
A Shared-Care Model for Autologous Transplantation: Feasibility and Optimization of Tertiary Center Resources
Ana Jiménez-Ubieto, Adolfo Jesús Sáez Marín, Paula Lázaro, José María Sánchez Pina, Rodrigo Iñiguez García, Magdalena Corona, Rafael Alonso, Laura Montejano, Pilar Martínez-Sánchez, Daniel Gil, Nieves López, Guillermo Ramos, Pilar Bravo, María Stefania Infante, José-Ángel Hernández-Rivas, Juan Churruca, Renata García Gigorro, Iryna Luts, Fernando Solano, Jacobo Galán Vega, Joaquín Martínez-López, M. Calbacho, Juan José Lahuerta Palacios
Synthesis, Evaluation, and Effect of Anti-CD38 Single-chain Immunotoxin on HL-60 acute myeloid Leukemia cell Line
Atefeh Habibi Asl, Reza Valadan, Saeid Taghiloo, Nazanin Joudaki, Hossein Asgarian-Omran, Ehsan Zaboli, Mahdieh Darvishkhezri, Abolghasem Ajami
Painful acrocyanosis as the predominant vascular feature of early anti-Scl-70 positive systemic sclerosis
Angelo Nigro
Academic manufacturing of anti-CD19 CAR-T cells from a leukapheresis with a high proportion of acute myeloid leukaemia blasts
Alexis Cuffel, Aurélie Bisson, Philippe Ruminy, Vinciane Rainville, Justine Dehayes, Arnaud Fleury, Clara Blondel, Maud Maho-Vaillant, Catherine Boutet, Véronique Saada, Célia Lobrano, Camille Giverne, Jérémie Martinet, Olivier Boyer, Jean-Baptiste Latouche
Frequently asked questions
How long does it take to publish?
4 days from submission to first decision; 42 days from submission to decision after review; 117 days from submission to acceptance; 1 day from acceptance to online publication.
Reformat to Current Research in Translational Medicine using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3950 excluding taxes. Subscription publication has no open access publication fee.
Reformat to Current Research in Translational Medicine using Livewrite Premium